| Jeffrey Ernest Wessell, DO | |
|
169 Ashley Ave Rm 202, Charleston, SC 29425-8905 | |
| (843) 792-3780 | |
| Not Available |
| Full Name | Jeffrey Ernest Wessell |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 169 Ashley Ave Rm 202, Charleston, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265961403 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | LL41059 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Ernest Wessell, DO 169 Ashley Avenue Room 202 Main Hospital Msc333, Charleston, SC 29425 Ph: () - | Jeffrey Ernest Wessell, DO 169 Ashley Ave Rm 202, Charleston, SC 29425-8905 Ph: (843) 792-3780 |
News Archive
SilverTree Health, the premier provider of physician billing and practice management resources, is pleased to announce a new marketing agreement between Desert Physicians Association (DPA) and its affiliate, Integra Physicians Network (IPN). This new partnership leverages the strengths of both organizations: SilverTree's high-tech nature and profitability and DPA's membership base.
Santarus, Inc. announced today the U.S. commercial launch of UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.
Summer, sun and the sea - a dream vacation for most - can turn sour for those affected by lupus erythematosus. For them, absorption of the UV-light component in sunlight may cause florid inflammation and redness of the skin. Scientists of the University Hospital Bonn, Germany have now discovered which signaling pathway of the innate immune system promotes autoimmune symptoms following sun-induced DNA damage.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today positive topline results from the interim analysis of the ENVISION Phase 3 Study of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 for the treatment of acute hepatic porphyria.
Value in Health, the official journal of ISPOR, announced today the publication of 2 studies confirming the value of including patients and other nonscientists in the process for approving research funding.
› Verified 5 days ago
Dr. Michael Charles O'laughlin, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-3072 | |
Kyler Perry, DO Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2300 | |
Dr. Swathi Venattu, MD Surgery Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Antwana Sharee Wright, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Jacob Arthur Klapper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Norman Robert Harvey, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-2123 | |
Hyejin Kwon, MD Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave, Charleston, SC 29425 Phone: 843-792-3072 |